On April 4-8 GEROPHARM participated in the thematic week "Import
substitution in regional economy. Days of the Republic of Tatarstan"
which took place at the Center of import substitution and localization
as a part of the collective exposition of the pharmaceutical cluster
"Medical and Pharmaceutical Projects: 21st Century".
The special guests of the event were the representatives of various
committees and departments, and also the members of Presidential
Administration. GEROPHARM presented to the wide audience of experts its
pipeline in the field of endocrinology, ophthalmology, neurology and
gynecology: genetically engineered human insulins –Rinsulin® R (short-acting) and Rinsulin®
NPH produced in threeforms: vials, cartridges, reusable pens, which
represent a successful project in the field of import substitution, and
original drug products Cortexin®, Cortexin® for children, Retinalamin®, Pineamin®, and generics Levetinol®, Memantinol®, Recognan®.
GEROPHARM is a participant of the state program "PHARMA-2020", which helps to implement the projects focused on import substitution of socially significant drug products. The key tasks of the Group are the development of manufacturing technology, in particular, the creation of a modern technological platform for the production of biotechnological drugs on the principle of a full cycle; ensuring the independence of the Russian insulin market from imported substances and market saturation with modern and high-effective products; meeting the demand of health care system for drug products in order to improve the quality of drug supply, and also the development of export potential of Russia in the field of pharmaceutical industry.